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CDC and 1 m M GCDC at pH 7.4 had no effect on cell viability, 
but at pH 6.4 decreased viability by  1 80% and increased cas-
pase activity almost 10- and 30-fold, respectively. Acidifica-
tion alone had no effect. AE2 knockdown led to 3- and 2-fold 
enhanced apoptosis induced by 0.75 m M CDC or 2 m M GCDC 
at pH 7.4.  Discussion: These data support our hypothesis of 
a biliary HCO3– umbrella serving to protect human cholangio-
cytes against bile acid-induced injury. AE2 is a key contri b-
utor to this protective mechanism. The development and 
progression of cholangiopathies, such as primary biliary cir-
rhosis, may be a consequence of genetic and acquired func-
tional defects of genes involved in maintaining the biliary 
HCO3– umbrella.  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Human biliary HCO 3– secretion accounts for 25–40% 
of total bile flow and by far exceeds that of rodents  [1] . The 
specific function of this pronounced HCO 3– secretion in 
humans is not understood. However, impaired function 
of anion exchanger 2 (AE2) and impaired HCO 3– secretion 
have been recognized as potential pathogenetic factors in 
primary biliary cirrhosis  [2–7] . We have recently specu-
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 Abstract 
 Background: Cholangiocytes expose a striking resistance 
against bile acids: while other cell types, such as hepato-
cytes, are susceptible to bile acid-induced toxicity and apo-
ptosis already at micromolar concentrations, cholangiocytes 
are continuously exposed to millimolar concentrations as 
present in bile. We present a hypothesis suggesting that bil-
iary secretion of HCO3– in man serves to protect cholangio-
cytes against bile acid-induced damage by fostering the de-
protonation of apolar bile acids to more polar bile salts. Here, 
we tested if bile acid-induced toxicity is pH-dependent and 
if anion exchanger 2 (AE2) protects against bile acid-induced 
damage.  Methods: A human cholangiocyte cell line was ex-
posed to chenodeoxycholate (CDC), or its glycine conjugate, 
from 0.5 m M to 2.0 m M at pH 7.4, 7.1, 6.7 or 6.4, or after knock-
down of AE2. Cell viability and apoptosis were determined 
by WST and caspase-3/-7 assays, respectively.  Results: Glyco-
chenodeoxycholate (GCDC) uptake in cholangiocytes is pH-
dependent. Furthermore, CDC and GCDC (pK a 4–5) induce 
cholangiocyte toxicity in a pH-dependent manner: 0.5 m M 
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lated that the pronounced biliary HCO 3– secretion in hu-
mans constitutes a protective mechanism of cholangio-
cytes against the toxicity of bile salts  [8] . Hydrophobic 
bile salts induce cytotoxicity in many cell types, includ-
ing hepatocytes, already at low micromolar concentra-
tions  [9–12] . In striking contrast, human biliary epithe-
lial cells are exposed to high millimolar concentrations of 
hydrophobic bile salts under physiologic conditions  [13] 
without any signs of cytotoxicity. 
 A major route of cytotoxicity induced by bile salts is 
apoptosis, which is mediated via intracellular signaling 
pathways  [9–12] . Penetrability of bile salts is determined 
by their polarity and protonation  [14] . Glycine conjugates 
account for the majority of bile salts in human bile, have 
a pK a of approximately 4  [15] and at physiologic pH are 
protonated, apolar and thus cell permeable at consider-
able, micromolar amounts. Even small changes in local 
biliary pH close to the apical membrane of cholangio-
cytes have a dramatic effect on the sensitivity of cholan-
giocytes towards glycine-conjugated bile salt toxicity. In 
rodents, which have a more hydrophilic, less toxic bile salt 
pool with mainly taurine conjugates  [13] (pK a of approx. 
1–2)  [15] , changes in biliary pH would have a minor, neg-
ligible effect on bile salt protonation and toxicity. pH de-
pendency of cell penetration and toxicity by bile salts has 
been established in gastric and esophageal mucosa cells 
 [16–18] . It was the aim of the present study to test the con-
cept of pH dependency of bile salt-induced toxicity in hu-
man cholangiocytes and to explore the role of AE2 ex-
pression in the protection against hydrophobic bile salt-
induced cholangiotoxicity.
 Methods 
 Two cholangiocarcinoma cell lines and an immortalized hu-
man cholangiocyte cell line were stimulated with the hydropho-
bic bile salt chenodeoxycholate (CDC) or its glycine and taurine 
conjugates at different pH from 7.4 to 6.4. Bile salt uptake was de-
termined by intracellular accumulation of  14 C-glycochenodeoxy-
cholate (GCDC), and cholangiotoxicity was determined by meta-
bolic activity (WST-1) and apoptosis assays (caspase-3/-7 activity). 
Cholangiocellular bile salt uptake and bile salt-induced apoptosis 
were also tested after knockdown of AE2 in immortalized human 
cholangiocytes by transduction with specific shRNA.
 Results 
 Cholangiocellular Bile Salt Uptake Is pH-Dependent 
 As calculated from the Henderson-Hasselbalch equa-
tion, protonation of chenodeoxycholate (CDC, pK a ap-
prox. 4) and its glycine conjugate GCDC (pK a approx. 4.2) 
are highly sensitive to changes of pH around the physio-
logic range, whereas TCDC (pK a approx. 2) stays virtu-
ally unaffected. Accordingly, intracellular accumulation 
of  14 C-GCDC in immortalized human cholangiocytes 
increased exponentially when pH was decreased from 7.4 
to 6.4 during bile salt incubation.
 Bile Salt-Induced Cholangiocellular Toxicity Is
pH-Dependent 
 In both cholangiocarcinoma cell lines and immortal-
ized human cholangiocytes, CDC- and GCDC-induced 
cholangiocyte toxicity, but not TCDC-induced, were pH-
dependent and increased gradually when pH was lowered 
from 7.4 to 7.1, 6.7 or 6.4. In immortalized cholangio-
cytes, no bile salt-induced toxicity was observed even at 
low millimolar concentrations of CDC (0.5 m M ), GCDC 
(1.5 m M ) or TCDC (2.0 m M ) at pH 7.4. At a lower pH of 
6.4, however, 0.5 m M CDC and 1 m M GCDC led to a de-
crease in cell viability by  1 80% and increased caspase-3/-7 
activity almost 10- and 30-fold, respectively. Acidifica-
tion alone had no effect on cell viability or apoptosis. 
TCDC-induced cell damage did not increase within the 
pH-range studied, reflecting its relative inertness in pro-
tonation in this range.
 Knockdown of AE2 Renders Cholangiocytes More 
Sensitive to Bile Salt-Induced Toxicity 
 AE2 knockdown in immortalized cholangiocytes led 
to a 3- and 2-fold increase of apoptosis induced by
0.75 m M CDC or 2 m M GCDC at pH 7.4. When increas-
ing pH to 8.0 during bile salt exposure, AE2 knockdown 
cells were rescued from bile salt toxicity. Again, TCDC-
induced toxicity was not affected by AE2 knockdown.
 Conclusion and Outlook 
 Our in vitro data indicate that penetration of bile salts 
into cholangiocytes is pH-dependent, as predicted from 
their pK a values. Accordingly, we demonstrated that bile 
salt-induced toxicity and apoptosis in cholangiocytes is 
determined by extracellular pH and that alkalization of 
bile close to the apical membrane of cholangiocytes via 
HCO 3– secretion might be a key protective mechanism 
against bile salt toxicity. By shRNA-mediated knock-
down, AE2 was confirmed as a candidate gene for forma-
tion of the postulated ‘biliary HCO 3– umbrella’  [8] .
 Our findings may delineate why HCO 3– secretion is 
highly pronounced in man compared to rodents, as pro-
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tonation of the mainly glycine-conjugated bile salt pool 
in man, but not of the less toxic mainly taurine-conjugat-
ed rodent bile salt pool, is sensitive to changes in biliary 
pH within the physiologic range  [8] .
 Our hypothesis of a human biliary ‘HCO 3– umbrella’, 
supported by the in vitro data provided here, provides a 
unifying link between the molecular pathogenesis and 
progressive course of different cholangiopathies  [8] . Ge-
netic variations of the candidate HCO 3–-secreting enzyme 
AE2 have been associated with improved prognosis of 
primary biliary cirrhosis  [2] , and mutations of the bile salt 
sensor TGR5, which mediates biliary HCO 3– secretion, 
have been associated with PSC  [19] . Altered maintenance 
of a transmembrane Cl – gradient, driving HCO 3– secre-
tion, or altered direct flux of HCO 3– via CFTR might con-
tribute to liver disease associated with cystic fibrosis. Fi-
nally, disrupted acetylcholine signaling after liver trans-
plantation, physiologically stimulating HCO 3– secretion, 
may contribute to the formation of nonanastomotic bili-
ary strictures following liver transplantation ( fig. 1 ). Fur-
ther experimental work is underway to (dis-)prove these 
speculations.
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 Fig. 1. The biliary HCO 3– umbrella. Several 
signaling pathways regulate the formation 
of the postulated biliary HCO3– umbrella 
 [8] . Dysfunction of any of the delineated 
elements  [20] might contribute to fibros-
ing/sclerosing cholangitis. Established 
and experimental therapeutic agents such 
as UDCA or norUDCA stabilize the bili-
ary HCO3– umbrella. ACh = Acetylcholine; 
ATP = adenosine trisphosphate; CA = car-
boanhydrase; CaCl = Ca++-dependent 
chloride channel; cAMP = cyclic adeno-
sine monophosphate; CDCA = chenode-
oxycholic acid; CFTR = cystic fibrosis 
transmembrane conductance regulator; 
ER = endoplasmic reticulum; P2Y = puri-
nergic P2Y receptors; SR = secretin recep-
tor; TGR5 = G protein-coupled bile acid 
receptor. 
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